Skip to content
Riskpilot
← Back to search
Sign in
Get full access
G.L. Pharma Nordic Aktiebolag
AB
Active
Org 5592488216
Övägen 1, 216 47
Limhamn
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2020
3 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
G.L. Pharma Nordic Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
23M
45M
68M
91M
33M
2021
42M
2022
73M
2023
79M
2024
0M
2025
EBITDA
SEK millions
0M
2M
4M
6M
8M
3M
2021
4M
2022
7M
2023
7M
2024
3M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
33 324
41 506
73 309
78 856
82
Staff expenses
—
—
—
—
—
EBITDA
3 036
3 706
6 732
6 946
3 156
Depreciation & amort.
−83
−83
−83
−83
−46
EBIT
2 953
3 623
6 649
6 863
3 110
Net financials
24
−343
695
−396
−289
Profit before tax
2 977
3 280
7 343
6 728
2 971
Tax
−621
−701
−1 536
−1 419
−654
Net profit
2 356
2 579
5 807
5 309
2 317
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
20 777
25 685
39 490
39 105
45 871
Equity
2 379
4 957
10 765
16 074
18 391
Long-term debt
0
0
0
0
0
Short-term debt
18 399
20 728
28 725
23 031
27 480
Total debt
18 399
20 728
28 725
23 031
27 480
Financial ratios
5-year trend
EBITDA margin
3848.8%
This company
15.8%
Market median
+24259% vs market
2021
2025
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
2021
2025
Return on equity
12.6%
This company
18.4%
Market median
+32% vs market
2021
2025
Net profit margin
2825.6%
This company
8.1%
Market median
+34784% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on G.L. Pharma Nordic Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
